Literature DB >> 28921118

Repeated total intravenous anesthesia for a patient with a history of enflurane-induced rhabdomyolysis.

Akiko Suzuki1, Eiji Hashiba1, Akinori Matsui1, Takeshi Kubota1, Hironori Ishihara1, Akitomo Matsuki1.   

Abstract

Entities:  

Keywords:  Progressive muscular dystrophy; Rhabdomyolysis; Total intravenous anesthesia

Year:  1997        PMID： 28921118     DOI： 10.1007/BF02480044

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  9 in total

Review 1.  Malignant hyperthermia: relationship to other diseases.

Authors:  A K Brownell
Journal:  Br J Anaesth       Date:  1988-02       Impact factor: 9.166

2.  Cardiac arrest during anesthetic induction in a child with Becker type muscular dystrophy.

Authors:  W A Marks; J B Bodensteiner; R D Reitz
Journal:  J Child Neurol       Date:  1987-04       Impact factor: 1.987

3.  Myoglobinuria and elevated serum enzymes associated with partial glossectomy under enflurane anesthesia in a patient with muscular dystrophy.

Authors:  M Umino; M Kurosa; T Masuda; Y Kubota
Journal:  J Oral Maxillofac Surg       Date:  1989-01       Impact factor: 1.895

4.  [Serum myoglobin value during enflurane anesthesia].

Authors:  S Shinohara; H Hazama; K Nozaki; K Kanao; S Ishihara; S Tsujioka
Journal:  Masui       Date:  1983-09

5.  Anesthesia-induced rhabdomyolysis in a patient with Duchenne's muscular dystrophy.

Authors:  E D Miller; D B Sanders; J C Rowlingson; F A Berry; M D Sussman; R M Epstein
Journal:  Anesthesiology       Date:  1978-02       Impact factor: 7.892

6.  Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses.

Authors:  K Arahata; E P Hoffman; L M Kunkel; S Ishiura; T Tsukahara; T Ishihara; N Sunohara; I Nonaka; E Ozawa; H Sugita
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Anaesthesia and progressive muscular dystrophy.

Authors:  C L Smith; G H Bush
Journal:  Br J Anaesth       Date:  1985-11       Impact factor: 9.166

8.  Malignant hyperthermia in a patient with Becker muscular dystrophy: dystrophin analysis and caffeine contracture study.

Authors:  N Ohkoshi; T Yoshizawa; H Mizusawa; S Shoji; M Toyama; K Iida; Y Sugishita; K Hamano; A Takagi; K Goto
Journal:  Neuromuscul Disord       Date:  1995-01       Impact factor: 4.296

9.  Malignant hyperthermia susceptibility in X-linked muscle dystrophies.

Authors:  T D Heiman-Patterson; H M Natter; H R Rosenberg; J E Fletcher; A J Tahmoush
Journal:  Pediatr Neurol       Date:  1986 Nov-Dec       Impact factor: 3.372
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.